Fariborz Keyhanfar

815 total citations
36 papers, 618 citations indexed

About

Fariborz Keyhanfar is a scholar working on Pharmacology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Fariborz Keyhanfar has authored 36 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Physiology and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Fariborz Keyhanfar's work include Pain Mechanisms and Treatments (7 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Drug Solubulity and Delivery Systems (4 papers). Fariborz Keyhanfar is often cited by papers focused on Pain Mechanisms and Treatments (7 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Drug Solubulity and Delivery Systems (4 papers). Fariborz Keyhanfar collaborates with scholars based in Iran, Czechia and United States. Fariborz Keyhanfar's co-authors include Manzumeh Shamsi Meymandi, Amir Amani, Hossein Hosseinzadeh, Seyed Ahmad Mohajeri, Reza Falak, Elaheh Abdollahi, Massoumeh Shafiei, Ali‐Akbar Delbandi, Manijeh Motevalian and Marziyeh Ajdary and has published in prestigious journals such as Psychopharmacology, European Journal of Pharmacology and Food and Chemical Toxicology.

In The Last Decade

Fariborz Keyhanfar

35 papers receiving 595 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fariborz Keyhanfar Iran 13 110 90 83 76 75 36 618
Aneta Wojnicz Spain 15 160 1.5× 68 0.8× 50 0.6× 32 0.4× 23 0.3× 30 705
Nengneng Cheng China 17 200 1.8× 112 1.2× 22 0.3× 74 1.0× 45 0.6× 36 598
Pamela Nardiello Italy 11 209 1.9× 51 0.6× 20 0.2× 148 1.9× 71 0.9× 14 718
Kai On Chu Hong Kong 21 203 1.8× 108 1.2× 82 1.0× 50 0.7× 66 0.9× 40 1.1k
Zhanzhang Wang China 11 178 1.6× 97 1.1× 39 0.5× 66 0.9× 24 0.3× 36 544
Gabriela Dogaru Romania 13 163 1.5× 103 1.1× 17 0.2× 124 1.6× 72 1.0× 85 893
Yannis V. Simos Greece 15 184 1.7× 43 0.5× 14 0.2× 104 1.4× 68 0.9× 70 874
Ji‐Young Moon South Korea 19 280 2.5× 98 1.1× 18 0.2× 168 2.2× 101 1.3× 41 908
Shan-Yu Su Taiwan 19 293 2.7× 181 2.0× 17 0.2× 95 1.3× 33 0.4× 62 1.1k

Countries citing papers authored by Fariborz Keyhanfar

Since Specialization
Citations

This map shows the geographic impact of Fariborz Keyhanfar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fariborz Keyhanfar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fariborz Keyhanfar more than expected).

Fields of papers citing papers by Fariborz Keyhanfar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fariborz Keyhanfar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fariborz Keyhanfar. The network helps show where Fariborz Keyhanfar may publish in the future.

Co-authorship network of co-authors of Fariborz Keyhanfar

This figure shows the co-authorship network connecting the top 25 collaborators of Fariborz Keyhanfar. A scholar is included among the top collaborators of Fariborz Keyhanfar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fariborz Keyhanfar. Fariborz Keyhanfar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jafarinejad‐Farsangi, Saeideh, et al.. (2022). Hydrophobic@amphiphilic hybrid nanostructure of iron-oxide and graphene quantum dot surfactant as a theranostic platform. OpenNano. 6. 100037–100037. 5 indexed citations
3.
Keyhanfar, Fariborz, et al.. (2022). Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor. BioMed Research International. 2022(1). 1111777–1111777. 2 indexed citations
4.
Haghparast, Amir, et al.. (2021). Cannabidiol microinjection into the nucleus accumbens attenuated nociceptive behaviors in an animal model of tonic pain. Neuroscience Letters. 762. 136141–136141. 4 indexed citations
5.
Ajdary, Marziyeh, et al.. (2021). Toxicity of silver nanoparticles on endometrial receptivity in female mice. Canadian Journal of Physiology and Pharmacology. 99(12). 1264–1271. 6 indexed citations
6.
Ajdary, Marziyeh, Fariborz Keyhanfar, Mohammad Amin Moosavi, et al.. (2021). Potential toxicity of nanoparticles on the reproductive system animal models: A review. Journal of Reproductive Immunology. 148. 103384–103384. 42 indexed citations
7.
8.
Keyhanfar, Fariborz, et al.. (2021). Therapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study.. PubMed. 20(4). 152–164. 5 indexed citations
9.
10.
Meymandi, Manzumeh Shamsi, et al.. (2017). The Contribution of NMDA Receptors in Antinociceptive Effect of Pregabalin: Comparison of Two Models of Pain Assessment. Anesthesiology and Pain Medicine. 7(3). e14602–e14602. 9 indexed citations
11.
Keyhanfar, Fariborz, et al.. (2015). Design and evaluation of oral nanoemulsion drug delivery system of mebudipine. Drug Delivery. 23(6). 2035–2043. 66 indexed citations
12.
Rahimi‐Moghaddam, Parvaneh, et al.. (2015). Commentary on prevention a possible drug-drug interaction: Is concurrent administration of orlistat and pioglitazone increase the risk of durg-induced hepatotoxicity?. International Journal of Preventive Medicine. 6(1). 16–16. 3 indexed citations
13.
Meymandi, Manzumeh Shamsi, et al.. (2015). The Role of NMDARs Ligands on Antinociceptive Effects of Pregabalin in the Tail Flick Test. Anesthesiology and Pain Medicine. 5(5). e28968–e28968. 9 indexed citations
14.
Keyhanfar, Fariborz, et al.. (2013). Evaluation of Antinociceptive Effect of Pregabalin in Mice and its Combination with Tramadol using Tail Flick Test.. PubMed. 12(3). 483–93. 30 indexed citations
15.
Keyhanfar, Fariborz, et al.. (2013). Improved Oral Bioavalability of Mebudipine Upon Administration in PhytoSolve and Phosal-Based Formulation (PBF). AAPS PharmSciTech. 15(1). 96–102. 11 indexed citations
16.
Meymandi, Manzumeh Shamsi & Fariborz Keyhanfar. (2013). Assessment of the antinociceptive effects of pregabalin alone or in combination with morphine during acetic acid-induced writhing in mice. Pharmacology Biochemistry and Behavior. 110. 249–254. 26 indexed citations
17.
Meymandi, Manzumeh Shamsi & Fariborz Keyhanfar. (2012). Relative potency of pregabalin, gabapentin, and morphine in a mouse model of visceral pain. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 60(1). 44–49. 17 indexed citations
18.
Meymandi, Manzumeh Shamsi & Fariborz Keyhanfar. (2012). Pregabalin antinociception and its interaction with tramadol in acute model of pain. Pharmacological Reports. 64(3). 576–585. 19 indexed citations
19.
Bohlooli, Shahab, Fariborz Keyhanfar, & Mehdi Mahmoudian. (2002). High performance liquid chromatography of mebudipine: application to pharmacokinetic study.. PubMed. 4(3). 244–7. 8 indexed citations
20.
Keyhanfar, Fariborz & John Caldwell. (1996). Factors affecting the metabolism of cinnamyl anthranilate in the rat and mouse. Food and Chemical Toxicology. 34(3). 241–249. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aneta Wojnicz Breakdown of academic impact, for papers by Nengneng Cheng Breakdown of academic impact, for papers by Pamela Nardiello Breakdown of academic impact, for papers by Kai On Chu Breakdown of academic impact, for papers by Zhanzhang Wang Breakdown of academic impact, for papers by Gabriela Dogaru Breakdown of academic impact, for papers by Yannis V. Simos Breakdown of academic impact, for papers by Ji‐Young Moon Breakdown of academic impact, for papers by Shan-Yu Su
Rankless by CCL
2026